1
Barry D Quart, Jean Luc Girardet, Esmir Gunic, Li Tain Yeh: Compounds and compositions and methods of use. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, December 27, 2011: US08084483 (17 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


2
Barry D Quart, Jean Luc Girardet, Esmir Gunic, Li Tain Yeh: Compounds and compositions and methods of use. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, October 9, 2012: US08283369 (7 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


3
Li Tain Yeh, Malcolm E Kenney, Gary N Bokerman, John P Cannady, Ollie W Marko: Alkoxysilanes and oligomeric alkoxysiloxanes by a silicate-acid route. Dow Corning Corporation, Case Western Reserve University, Roger E Gobrogge, February 2, 1993: US05183914 (7 worldwide citation)

The present invention relates to a novel method of preparing alkoxysilanes and oligomeric alkoxysiloxanes. The method comprises reacting a metal silicate with an acid selected from the group consisting of sulfurous acid and acids with a pKa greater than about 2.5 in the presence of an alcohol. The r ...


4
Barry D Quart, Jean Luc Girardet, Esmir Gunic, Li Tain Yeh: Compounds and compositions and methods of use. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, January 22, 2013: US08357713 (5 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


5
Barry D Quart, Jean Luc Girardet, Esmir Gunic, Li Tain Yeh: Compounds and compositions and methods of use. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, October 1, 2013: US08546437 (3 worldwide citation)

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


6
Barry D QUART, Jean Luc GIRARDET, Esmir GUNIC, Li Tain YEH: Novel compounds and compositions and methods of use. Ardea Biosciences, Wilson Sonsini Goodrich & Rosati, August 6, 2009: US20090197825-A1

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


7
Barry D Quart, Jean Luc Girardet, Esmir Gunic, Li Tain Yeh: Novel compounds and compositions and methods of use. Ardea Biosciences, December 1, 2011: US20110293719-A1

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


8
Barry D Quart, Jean Luc Girardet, Esmir Gunic, Li Tain Yeh: Novel compounds and compositions and methods of use. Ardea Biosciences, November 3, 2011: US20110268801-A1

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.


9
Barry D Quart, Jean Luc Girardet, Esmir Gunic, Li Tain Yeh: Novel compounds and compositions and methods of use. Ardea Biosciences, June 28, 2012: US20120164222-A1

Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.